Powered by
-
TNDM Stock Chart
Historical TNDM Prices
Tandem Diabetes Care Stock Analysis
Rating: Buy
Total Grade: B
Analysis Breakdown
| TNDM Stock Grade: | B |
| Fundamental Grade: | D |
| Quantitative Grade: | A |
| TNDM Earnings | |
| Earnings Growth: | C |
| Earnings Momentum: | F |
| Earnings Surprises: | F |
| Analyst Earnings Revisions: | F |
| TNDM Financial Information | |
| Sales Growth: | A |
| Operating Margin Growth: | C |
| Cash Flow: | F |
| Return on Equity: | F |
Tandem Diabetes Care Stock: Weekly View
| This Week: | B |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |
TNDM Stock predictions, Articles, and Tandem Diabetes Care News
- From InvestorPlace
- From the Web
-
5 Healthcare Stocks to Buy for Complete Portfolio Wellness - October 10, 2018
Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight. Continue…
-
Tandem Diabetes Is Firing on All Cylinders - September 11, 2018
Tandem Diabetes sold shares of TNDM stock, but Tandem Diabetes stock continued to rocket higher. TNDM's Q2 results impressed investors, but its seasonally strong Q4 earnings could wow them more. Continue…
-
Why Tandem Stock Could Continue Its Rally - June 25, 2018
Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside. Continue…
-
Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet - April 13, 2018
Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock. Continue…
-
4 Top Growth Picks as MedTech Battle Rages On - October 16, 2017
Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector. Continue…
